These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2047543)

  • 41. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasoactive intestinal peptide in the hypothalamus and pituitary.
    Lam KS
    Neuroendocrinology; 1991; 53 Suppl 1():45-51. PubMed ID: 1901391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Para-chlorophenylalanine treatment inhibits the expression of vasoactive intestinal peptide messenger RNA in rat anterior pituitary.
    Signs SA; Dluzen DE; Carrillo AJ
    Brain Res Mol Brain Res; 1993 Jan; 17(1-2):36-40. PubMed ID: 8381907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
    Gómez O; Balsa JA
    Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central galanin stimulates pituitary prolactin secretion in rats: possible involvement of hypothalamic vasoactive intestinal polypeptide.
    Koshiyama H; Kato Y; Inoue T; Murakami Y; Ishikawa Y; Yanaihara N; Imura H
    Neurosci Lett; 1987 Mar; 75(1):49-54. PubMed ID: 2437498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperprolactinemia-induced modifications in vasoactive intestinal peptide binding site densities in the rat central nervous system and pituitary gland: evidence for an interaction between estradiol-17 beta and prolactin effects.
    Montagne MN; Vial M; Joubert-Bression D; Rostène W
    Brain Res; 1989 Apr; 485(2):258-66. PubMed ID: 2541867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells.
    Hagen TC; Arnaout MA; Scherzer WJ; Martinson DR; Garthwaite TL
    Neuroendocrinology; 1986; 43(6):641-5. PubMed ID: 3762862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of dopaminergic and peptidergic factors in the control of prolactin release.
    Mogg RJ; Samson WK
    Endocrinology; 1990 Feb; 126(2):728-35. PubMed ID: 2298169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system.
    Lara JI; Lorenzo MJ; Cacicedo L; Tolón RM; Balsa JA; López-Fernández J; Sánchez-Franco F
    Endocrinology; 1994 Dec; 135(6):2526-32. PubMed ID: 7988440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.
    Pizzi M; Memo M; Benarese M; Simonazzi E; Missale C; Spano PF
    Neuroendocrinology; 1990 Apr; 51(4):481-6. PubMed ID: 2161088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W; Benoist L; Besson J; Duval J
    C R Seances Acad Sci D; 1980 Mar; 290(12):791-3. PubMed ID: 6769606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Superior cervical ganglionectomy differentially modifies median eminence and anterior and mediobasal hypothalamic GABA content in male rats: effects of hyperprolactinemia.
    Esquifino AI; Alvarez MP; Cano P; Jiménez V; Duvilanski B
    Exp Brain Res; 2004 Aug; 157(3):296-302. PubMed ID: 14985901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine infusion into the third ventricle increases gene expression of hypothalamic vasoactive intestinal peptide and pituitary prolactin and luteinizing hormone beta subunit in the turkey.
    Bhatt R; Youngren O; Kang S; El Halawani M
    Gen Comp Endocrinol; 2003 Jan; 130(1):41-7. PubMed ID: 12535623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of prolactin gene expression by vasoactive intestinal peptide and dopamine in the turkey: role of Ca signalling.
    Al Kahtane A; Kannan M; Kang SW; El Halawani ME
    J Neuroendocrinol; 2005 Oct; 17(10):649-55. PubMed ID: 16159377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasoactive intestinal peptide stimulates gonadotropin-releasing hormone release from rat hypothalamus in vitro.
    Ohtsuka S; Miyake A; Nishizaki T; Tasaka K; Tanizawa O
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):399-402. PubMed ID: 3289303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
    Lam KS; Reichlin S
    Neuroendocrinology; 1989 Nov; 50(5):524-8. PubMed ID: 2514393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diurnal variation in the effect of potassium depolarization on vasoactive intestinal polypeptide release from rat hypothalamus: a possible role for adrenaline.
    Burns G; Brown BL; Dobson PR
    J Endocrinol; 1988 Mar; 116(3):335-41. PubMed ID: 3127518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release.
    Rotsztejn WH; Benoist L; Besson J; Beraud G; Bluet-Pajot MT; Kordon C; Rosselin G; Duval J
    Neuroendocrinology; 1980 Oct; 31(4):282-6. PubMed ID: 7422069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of prolactin release by vasoactive intestinal peptide (VIP).
    Ruberg M; Rotsztejn WH; Arancibia S; Besson J; Enjalbert A
    Eur J Pharmacol; 1978 Oct; 51(3):319-20. PubMed ID: 710507
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.